Article info
Symposium on drugs
Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence
- Correspondence to: Prof W Hall Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia QLD, Australia 4072; w.hallimb.uq.edu.au
Citation
Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence
Publication history
- Received May 14, 2003
- Accepted May 15, 2003
- First published August 2, 2004.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by the Journal of Medical Ethics
Other content recommended for you
- Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter
- Cocaine and the heart
- Genetic risk factors influenced cocaine abuse and dependence more than cocaine use in women
- A research agenda for assessing the potential contribution of genomic medicine to tobacco control
- Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy
- Central and autonomic system signs with in utero drug exposure
- Self-reported cocaine use, emergency physician testing and outcomes in suspected acute coronary syndromes: a nested matched case–control study
- Prenatal drug exposure and maternal and infant feeding behaviour
- Vaccination against tuberculosis in badgers and cattle: an overview of the challenges, developments and current research priorities in Great Britain
- Silent myocardial damage in cocaine addicts